Skip to Content
Merck
  • Design, synthesis and antihistamine evaluations of several N-hydroxyalkyl desloratadine analogues.

Design, synthesis and antihistamine evaluations of several N-hydroxyalkyl desloratadine analogues.

Medicinal chemistry (Shariqah (United Arab Emirates)) (2012-07-12)
Yan Lin, Yue Wang, Li-feng Sima, Dong-hua Wang, Li-gong Chen, Lei Li
ABSTRACT

Several N-hydroxyalkyl desloratadines and N-methoxyl ethyl desloratadine were prepared and evaluated for H1 antihistamine activity. The effects on isolated ileum smooth muscle tension in guinea pigs in vitro and asthma-relieving effects on the histamine-induced asthmatic reaction in guinea-pigs in vivo were examined. Most of them exhibited satisfactory H1 antihistamine activity and were obviously more potent than loratadine. Among these, Compound 3, N-(3-hydroxy)propyl desloratadine was the most active one. And it was chosen as a candidate for evaluation of acute toxicity (LD(50)= 0.876(0.784-0.980) g/kg), significantly superior to that of desloratadine (LD(50)=0.353 g/kg). Meanwhile, the experimental results demonstrated that the oxygen atom in the side carbon chain is crucial for enhancing the antihistamine activities.

MATERIALS
Product Number
Brand
Product Description

Loratadine for system suitability, European Pharmacopoeia (EP) Reference Standard
Loratadine, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Loratadine, ≥98% (HPLC), powder